College of Natural Sciences, Department of Biology, Jimma University, Jimma, Ethiopia.
J Epidemiol Glob Health. 2024 Sep;14(3):884-904. doi: 10.1007/s44197-024-00231-7. Epub 2024 May 2.
Soil-transmitted helminthic (STH) infections are the leading cause of stunting among children. To lessen the burden, the World Health Organization (WHO) recommended a periodic deworming program through the use of single-dose therapy in the endemic regions. Therefore, the purpose of this study was to synthesize evidence about the efficacy of anthelminthic drugs against STH infections among preschool and school-age children.
The Preferred Reposting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria were followed in this study. Relevant electronic databases, including PubMed, Scopus, Embase, DOAJ, Science Direct, the WHO Clinical Trials.gov library, Google Scholar, and AJOL databases, were searched for relevant publications. Randomized controlled trials (RCTs) and non-randomized interventional studies focused on the efficacy of albendazole and mebendazole against STHs in children were included in the study. Review Manager was used to analyze the data. A random effects model was used to obtain the pooled estimated efficacy. To evaluate heterogeneity, the I test and Cochrane Q (χ) were employed. The risk of publication bias was investigated using Egger's test and the funnel plot. The protocol of this review was registered at the PROSPERO international prospective register of systematic reviews (CRD42023401196).
Of the 69 publications selected for the systematic review, 66 with complete data were included in the meta-analysis. Single doses of albendazole and mebendazole have shown satisfactory efficacy [egg reduction rate (ERR)] against Ascaris lumbricoides [95.54% (95% CI: 88.75-102.34%) and 98.69% (95% CI: 97.68-99.65%), respectively. The effectiveness of these two drugs against Trichuris trichiura and hookworms was comparatively low (< 80% ERR), except for albendazole, which showed high ERRs [93.44% (95%CI: 92.39-94.49%)] against hookworms. The cure rate (CR) of albendazole against T. trichiura, A. lumbricoides, and hookworms were 50.8%, 91.3%, and 78.32%, respectively. Likewise, mebendazole showed CRs of 48.15%, 92.8%, and 49.32% against T. trichiura, A. lumbricoides, and hookworms, respectively. Subgroups such as studies conducted after 2000, diagnostic type (McMaster), and longer follow-up weeks significantly reduced the efficacy of the two drugs against T. trichura. While the combination of albendazole or mebendazole with other drugs and RCT showed significantly improved efficacy against T. trichura. The count of eggs per gram of stool (EPG) was identified as one of the variables that negatively and significantly influenced the efficacy of albendazole or mebendazole against A. lumbricoides.
Despite the wide range of ERRs and CR reported in the different articles included in this review, the pooled estimated efficacy of albendazole and mebendazole against STHs falls in the satisfactory category of WHO recommendations. Further evaluation of the combination of anthelminthic drugs as a preventive chemotherapy option and routine drug efficacy testing are necessary to prevent the emergence and widespread use of drug-resistant STHs.
土壤传播性蠕虫(STH)感染是导致儿童发育迟缓的主要原因。为了减轻负担,世界卫生组织(WHO)建议在流行地区使用单剂量疗法定期进行驱虫。因此,本研究的目的是综合评估驱虫药物对学龄前和学龄儿童 STH 感染的疗效。
本研究遵循了系统评价和荟萃分析的首选报告项目(PRISMA)标准。检索了相关的电子数据库,包括 PubMed、Scopus、Embase、DOAJ、Science Direct、世界卫生组织临床试验注册库、谷歌学术和 AJOL 数据库,以查找相关出版物。本研究纳入了针对阿苯达唑和甲苯达唑治疗儿童 STH 的疗效的随机对照试验(RCT)和非随机干预性研究。使用 Review Manager 分析数据。采用随机效应模型获得汇总估计疗效。使用 I 检验和 Cochrane Q(χ)评估异质性。使用 Egger 检验和漏斗图评估发表偏倚的风险。本综述的方案在 PROSPERO 国际系统评价前瞻性注册库(CRD42023401196)中进行了注册。
在系统评价中选择的 69 篇文献中,有 66 篇具有完整数据的文献被纳入荟萃分析。阿苯达唑和甲苯达唑的单剂量治疗对蛔虫(Ascaris lumbricoides)显示出令人满意的驱虫效果(卵减少率(ERR))[分别为 95.54%(95%CI:88.75-102.34%)和 98.69%(95%CI:97.68-99.65%)]。这两种药物对鞭虫和钩虫的疗效相对较低(<80%ERR),但阿苯达唑对钩虫的疗效较高(93.44%(95%CI:92.39-94.49%))。阿苯达唑对鞭虫、蛔虫和钩虫的治愈率(CR)分别为 50.8%、91.3%和 78.32%。同样,甲苯达唑对鞭虫、蛔虫和钩虫的 CR 分别为 48.15%、92.8%和 49.32%。在 2000 年后进行的研究、诊断类型(麦克马斯特)和更长的随访周等亚组中,这两种药物对鞭虫的疗效显著降低。而阿苯达唑或甲苯达唑与其他药物联合使用以及 RCT 则显著提高了对鞭虫的疗效。粪便中每克虫卵数(EPG)被确定为影响阿苯达唑或甲苯达唑对蛔虫疗效的一个负面且显著的变量。
尽管本综述中不同文章报告的 ERR 和 CR 范围很广,但阿苯达唑和甲苯达唑对 STH 的汇总估计疗效属于 WHO 推荐的满意类别。有必要进一步评估驱虫药物联合作为预防性化疗选择以及常规药物疗效测试,以防止出现和广泛使用耐药性 STH。